Sign in
AKUS Stock Price, Chart, Stats & News
Akouos, Inc.
Save
Akouos, Inc. (AKUS) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
AKUS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -31.09% |
ROE | -31.85% |
D/E | 0.12x |
Interest coverage ratio | – |
AKUS valuation
P/E | – |
P/S | – |
P/B | 1.00x |
P/CF | -3.66x |
P/FCF | – |
P/OCF | -3.66x |
PEG | -0.03x |
EV multiple | -1.12x |
About
Akouos, Inc. is a company dedicated to precise genetic medicine, developing gene therapies with the aim of restoring, enhancing, and safeguarding individuals' natural auditory function. Central to its strategy is an advanced genetic medicine platform, which incorporates a proprietary library of adeno-associated viral vectors and an innovative delivery method. The firm's leading experimental therapy is AK-OTOF, a gene therapy designed to treat hearing impairment caused by mutations in the OTOF gene.
Similar securities
Based on sector and market capitalization
Report issue